Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Prenetics Global Ltd PRE

Alternate Symbol(s):  PREJF

Financial Services Healthcare Insurance - Reinsurance Biotechnology
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool... see more

Recent & Breaking News (NDAQ:PRE)

Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth

GlobeNewswire 1 day ago

Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History

GlobeNewswire 5 days ago

Prenetics Announces Third Quarter 2025 Financial Results Release Date and Inaugural Earnings Conference Call

GlobeNewswire 10 days ago

Prenetics' IM8 Achieves Record $9 Million in Revenue for October, Surpasses $108 Million in Annualized Recurring Revenue 11 Months After Launch

GlobeNewswire 11 days ago

Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 Bitcoin, IM8 Reaches $100M ARR

GlobeNewswire October 31, 2025

Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manifesto: A Blueprint for the Future of Health + Wealth

GlobeNewswire October 29, 2025

Prenetics Announces Closing of Approx. $44.0 Million Equity Offering to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy

GlobeNewswire October 28, 2025

Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy

GlobeNewswire October 27, 2025

Prenetics Announces $48.0 Million Equity Offering to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy

GlobeNewswire October 27, 2025

Prenetics Global Limited Announces Proposed Public Offering

GlobeNewswire October 24, 2025

Prenetics' IM8 Launches Daily Ultimate Longevity, First Supplement to Target All 12 Hallmarks of Aging

GlobeNewswire October 8, 2025

Prenetics Completes $72 Million ACT Exit, Bolsters Cash and Bitcoin Treasury to Accelerate IM8's Path to $100 Million ARR

GlobeNewswire October 7, 2025

Prenetics Announces CEO Danny Yeung Keynote at Token 2049 Singapore

GlobeNewswire September 30, 2025

Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year's End

GlobeNewswire September 12, 2025

Prenetics' IM8 Congratulates Global Ambassador and Shareholder - World No. 1 Aryna Sabalenka on Defending Her US Open Championship

GlobeNewswire September 8, 2025

World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and Shareholder

GlobeNewswire June 26, 2025

Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board

GlobeNewswire June 18, 2025

Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction

GlobeNewswire June 18, 2025

Prenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement Soon

GlobeNewswire June 12, 2025

IM8 Vibrante Miami: Fueling Wellness and Innovation with a Star-Studded Event

GlobeNewswire April 9, 2025